Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hereditary intestinal polyposis syndromes

P A Dean1

  • 1Department of Surgery, University of Alabama-Birmingham 35294-0007, USA.

Revista De Gastroenterologia De Mexico
|April 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bis(tetraphenylphosphonium) tris(oxalato-O,O')germanate(IV).

Acta crystallographica. Section C, Crystal structure communications·2001
Same author

Synthesis, structure, and multi-NMR studies of (Me4N)[A(M(SC(O)Ph)3)2] (A = Na, M = Hg; A = K, M = Cd or Hg).

Inorganic chemistry·2001
Same author

Expandable metal stents for the treatment of colonic obstruction: techniques and outcomes.

Gastrointestinal endoscopy·1998
Same author

Spontaneously colitic C3H/HeJBir mice demonstrate selective antibody reactivity to antigens of the enteric bacterial flora.

Journal of immunology (Baltimore, Md. : 1950)·1997
Same author

Treatment of colonic obstruction with expandable metal stents: radiologic features.

AJR. American journal of roentgenology·1997
Same author

Long-term causes of death following ileal pouch-anal anastomosis.

Diseases of the colon and rectum·1996
Same journal

[Severe bowel complications in SARS-CoV-2 patients receiving protocolized care].

Revista de gastroenterologia de Mexico·2024
Same journal

[Liver injury due to COVID-19 in critically ill adult patients. A retrospective study].

Revista de gastroenterologia de Mexico·2023
Same journal

[Reactive ileal lymphoid hyperplasia related to SARS-CoV-2 infection as a unique clinical feature resembling Crohn's disease].

Revista de gastroenterologia de Mexico·2022
Same journal

[Intestinal pseudo-obstruction: A rare presentation of congenital hypothyroidism].

Revista de gastroenterologia de Mexico·2022
Same journal

[Impact on the incidence of gastrointestinal perforation during the COVID-19 pandemic in the <i>Costa del Sol</i> healthcare system area].

Revista de gastroenterologia de Mexico·2022
Same journal

[Two consecutive attacks of diarrhea in 15 COVID-19 patients: An antibiotic-associated one following the viral one].

Revista de gastroenterologia de Mexico·2021
See all related articles

Hereditary intestinal polyposis syndromes increase colorectal cancer risk. Early diagnosis and tailored treatments, including prophylactic surgery and genetic testing, significantly reduce mortality from these cancers.

Area of Science:

  • Gastroenterology
  • Oncology
  • Genetics

Background:

  • Colorectal cancer (CRC) is a leading cause of cancer mortality worldwide.
  • Hereditary intestinal polyposis syndromes significantly elevate CRC risk, necessitating targeted screening and prevention strategies.
  • These syndromes involve the development of numerous polyps, increasing the likelihood of malignant transformation.

Purpose of the Study:

  • To review recent advancements in understanding hereditary intestinal polyposis syndromes.
  • To emphasize clinical diagnostic and treatment approaches for cancer prevention.
  • To provide an updated overview of managing patients at high risk for colorectal cancer.

Main Methods:

  • Literature review of hereditary intestinal polyposis syndromes.

Related Experiment Videos

  • Analysis of clinical manifestations, genetic factors, and treatment outcomes.
  • Synthesis of current knowledge on diagnosis and management strategies.

    • Main Results:

    • Familial adenomatous polyposis (FAP) is the most common syndrome, characterized by extensive polyps and early-onset CRC, preventable by prophylactic colectomy.
    • Variant FAP syndromes (e.g., Turcot's syndrome) and hamartomatous polyposis syndromes (e.g., Juvenile Polyposis, Peutz-Jeghers syndrome) also confer significant CRC risk.
    • Genetic analysis has improved molecular understanding and enabled DNA testing for predisposed individuals, guiding personalized treatment strategies.

    Conclusions:

    • Advances in treatment and vigilant screening in at-risk families are crucial for reducing CRC-related mortality.
    • Personalized management based on specific genetic profiles and syndrome types optimizes cancer prevention.
    • Early detection and intervention in hereditary polyposis syndromes are key to improving patient outcomes.